← Back to Search

Behavioral Intervention

Audio Recordings for Advanced Prostate Cancer

N/A

Waitlist Available

Led By Daniel Kwon, MD

Research Sponsored by University of California, San Francisco

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Current or prior receipt of at least one androgen-signaling inhibitors (ASI) (abiraterone, enzalutamide, apalutamide, or darolutamide), with progression on it

Metastatic castration-resistant prostate cancer (mCRPC) with progression per any Prostate Cancer Working Group 3 (PCWG3) criterion (Prostate-specific antigen (PSA), clinical, or radiographic)

Timeline

Screening 3 weeks

Treatment Varies

Follow Up up to 60 days

Awards & highlights

Study Summary

This trial is testing a mobile app that lets patients record consultations with their doctors to see if it helps manage their metastatic prostate cancer.

Who is the study for?

This trial is for men with advanced prostate cancer that's resistant to hormone therapy and has never had chemotherapy. They must be able to use an English-only mobile app, have at least one prior treatment with specific drugs, and be planning a discussion about treatment options at UCSF soon. Participants need access to a smartphone or tablet (and a second device for video calls).Check my eligibility

What is being tested?

The study tests a mobile app that records audio during consultations for men with metastatic castrate-resistant prostate cancer. It aims to see if listening back to these recordings helps in making informed decisions regarding their treatment.See study design

What are the potential side effects?

Since the intervention involves using an app rather than medication, traditional side effects are not expected. However, participants may experience emotional or psychological impacts from hearing their medical consultations replayed.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have taken hormone therapy for cancer and my cancer got worse on it.

Select...

My prostate cancer has spread and is not responding to hormone therapy.

Select...

I am 18 years old or older.

Select...

I have never had chemotherapy for prostate cancer.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ up to 60 days

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~up to 60 days

This trial's timeline: 3 weeks for screening, Varies for treatment, and up to 60 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Mean change in informed subscale of Decisional Conflict Scale over time

Secondary outcome measures

Mean change in participant-reported anxiety over time

Proportion of approached patients' providers who agree to be recorded

Proportion of enrolled participants who create a recording

+5 more

Other outcome measures

Auto-generated transcript accuracy

Mean change in docetaxel knowledge score over time

Quality of decision support and communication

Trial Design

1Treatment groups

Experimental Treatment

Group I: Consultation audio recordingExperimental Treatment1 Intervention

Instructions on installation and detailed use of chosen application will be provided before an upcoming oncology visit. Research staff will contact the participant and encourage a "practice" recording session. 15-30 minutes prior to the consultation, research staff will send an anonymous text message to the participants' mobile device with a reminder to record the visit. Three days after the consultation, research staff will send an anonymous text reminder message to the participants' mobile device to listen to the recording.

0 / 4Eligibility criteria met

Find a Location

Who is running the clinical trial?

University of California, San FranciscoLead Sponsor

2,500 Previous Clinical Trials

15,236,420 Total Patients Enrolled

51 Trials studying Prostate Cancer

16,982 Patients Enrolled for Prostate Cancer

Conquer Cancer FoundationOTHER

19 Previous Clinical Trials

3,924 Total Patients Enrolled

Daniel Kwon, MDPrincipal InvestigatorUniversity of California, San Francisco

4 Previous Clinical Trials

597 Total Patients Enrolled

3 Trials studying Prostate Cancer

570 Patients Enrolled for Prostate Cancer

Media Library

Consultation Audio Recording App (Behavioral Intervention) Clinical Trial Eligibility Overview. Trial Name: NCT05127850 — N/A

Prostate Cancer Research Study Groups: Consultation audio recording

Prostate Cancer Clinical Trial 2023: Consultation Audio Recording App Highlights & Side Effects. Trial Name: NCT05127850 — N/A

Consultation Audio Recording App (Behavioral Intervention) 2023 Treatment Timeline for Medical Study. Trial Name: NCT05127850 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is the current participant enrollment for this trial?

"Affirmative, according to clinicaltrials.gov the recruitment process of this trial is ongoing. It was initially posted on March 22nd 2022 and recently updated on July 27th 2022. This research project requires 55 participants that will be enrolled at one medical site."

Answered by AI

Is this experiment in search of new participants currently?

"According to the clinicaltrials.gov portal, this experiment is currently looking for volunteers; it was first unveiled on March 22nd 2022 and has been refreshed as recently as July 27th 2022."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

MENCORE-2: Audio Recordings to Improve Decision-making in Advanced Prostate Cancer

2022. "MENCORE-2: Audio Recordings to Improve Decision-making in Advanced Prostate Cancer". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05127850.

All > Advanced Prostate Cancer